Common Contracts
42 similar Underwriting Agreement contracts by BigCommerce Holdings, Inc., Life Time Group Holdings, Inc., 2U, Inc., others
●] Shares ASTERA LABS, INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • March 8th, 2024 • Astera Labs, Inc. • Semiconductors & related devices • New York
UNDERWRITING AGREEMENTUnderwriting Agreement • November 13th, 2023 • Spirit AeroSystems Holdings, Inc. • Aircraft parts & auxiliary equipment, nec • New York
The undersigned understands that Morgan Stanley & Co. LLC (“Morgan Stanley”) proposes to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Spirit AeroSystems Holdings, Inc., a Delaware corporation (the “Company”), providing for the public offering (the “Public Offering”) by the several Underwriters, including Morgan Stanley (the “Underwriters”), of 9,090,909 shares (the “Shares”) of Class A common stock, par value $0.01 per share, of the Company (the “Common Stock”).
19,728,189 Shares CEREVEL THERAPEUTICS HOLDINGS, INC. COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • October 12th, 2023 • Cerevel Therapeutics Holdings, Inc. • Pharmaceutical preparations • New York
Cerevel Therapeutics Holdings, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom Goldman Sachs & Co. LLC (“Goldman”) is acting as representative (the “Representative”), 19,728,189 shares of its common stock, par value $0.0001 per share set forth in Schedule II hereto (the “Firm Shares”). The Company also proposes to issue and sell to the several Underwriters not more than an additional 2,959,228 shares of its common stock, par value $0.0001 per share set forth in Schedule II hereto (the “Additional Shares”) if and to the extent that the Representative shall have determined to exercise, on behalf of the Underwriters, the right to purchase such shares of common stock granted to the Underwriters in Section 2 hereof. The Firm Shares and the Additional Shares are hereinafter collectively referred to as the “Shares.” The shares of common stock, par value $0.0001 per share, of the Comp
2,727,273 Shares IMMUNEERING CORPORATION CLASS A COMMON STOCK (PAR VALUE $0.001 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • April 19th, 2023 • Immuneering Corp • Pharmaceutical preparations • New York
13,750,000 Shares INSMED INCORPORATED Common Stock, Par Value $0.01 Per Share UNDERWRITING AGREEMENTUnderwriting Agreement • October 20th, 2022 • INSMED Inc • Pharmaceutical preparations • New York
●] Shares REV RENEWABLES, INC. COMMON STOCK, PAR VALUE $0.01 PER SHARE FORM OF UNDERWRITING AGREEMENTUnderwriting Agreement • March 22nd, 2022 • REV Renewables, Inc. • Electric services • New York
l ] Shares USERTESTING, INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • November 8th, 2021 • UserTesting, Inc. • Services-prepackaged software • New York
7,000,000 Shares AIRSCULPT TECHNOLOGIES, INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT October 28, 2021Underwriting Agreement • November 2nd, 2021 • Airsculpt Technologies, Inc. • Services-offices & clinics of doctors of medicine • New York
The undersigned understands that Morgan Stanley & Co. LLC (“Morgan Stanley”), Piper Sandler & Co., and SVB Leerink LLC (together, the “Representatives”) proposes to enter into an Underwriting Agreement (the “Underwriting Agreement”) with AirSculpt Technologies, Inc., a Delaware corporation (the “Company”), providing for the public offering (the “Public Offering”) by the several Underwriters, including the Representatives (the “Underwriters”), of 7,000,000 shares (the “Shares”) of the common stock, par value $0.001 per share of the Company (the “Common Stock”).
•] Shares GLOBALFOUNDRIES Inc. ORDINARY SHARES, PAR VALUE $0.02 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • October 26th, 2021 • GLOBALFOUNDRIES Inc. • Semiconductors & related devices • New York
l ] Shares ALLBIRDS, INC. CLASS A COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • October 25th, 2021 • Allbirds, Inc. • Apparel & other finishd prods of fabrics & similar matl • New York
Allbirds, Inc., a Delaware public benefit corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule II hereto (the “Underwriters”), and certain shareholders of the Company (the “Selling Shareholders”) named in Schedule I hereto severally propose to sell to the several Underwriters, an aggregate of [ l ] shares of the Class A common stock, par value $0.0001 per share, of the Company (the “Firm Shares”), of which [ l ] shares are to be issued and sold by the Company and [ l ] shares are to be sold by the Selling Shareholders, each Selling Shareholder selling the amount set forth opposite such Selling Shareholder’s name in Schedule I hereto.
Shares P10, INC. CLASS A COMMON STOCK (PAR VALUE $0.001 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • October 12th, 2021 • P10, Inc. • Investment advice • New York
•] Shares of Common Stock Life Time Group Holdings, Inc. Shares of Common Stock (par value $0.01 per share) UNDERWRITING AGREEMENTUnderwriting Agreement • September 29th, 2021 • Life Time Group Holdings, Inc. • Services-membership sports & recreation clubs • New York
•] Shares of Common Stock Life Time Group Holdings, Inc. Shares of Common Stock (par value $0.01 per share) UNDERWRITING AGREEMENTUnderwriting Agreement • September 13th, 2021 • Life Time Group Holdings, Inc. • Services-membership sports & recreation clubs • New York
Traeger, Inc. [•] SHARES OF COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • July 21st, 2021 • TGPX Holdings I LLC • Household appliances • New York
•] Shares CYTEK BIOSCIENCES, INC. COMMON STOCK (PAR VALUE $0.001 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • July 19th, 2021 • Cytek BioSciences, Inc. • Laboratory analytical instruments • New York
•] Shares CONFLUENT, INC. CLASS A COMMON STOCK, PAR VALUE $0.00001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • June 16th, 2021 • Confluent, Inc. • Services-prepackaged software • New York
●] Shares DOXIMITY, INC. CLASS A COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • June 15th, 2021 • Doximity, Inc. • Services-computer programming services • New York
Morgan Stanley & Co. LLC Goldman Sachs & Co. LLC J.P. Morgan Securities LLC c/o Morgan Stanley & Co. LLC 1585 Broadway New York, NY 10036 c/o Goldman Sachs & Co. LLC 200 West Street New York, NY 10282 c/o J.P. Morgan Securities LLC 383 Madison Avenue New York, NY 10179
•] Shares WALKME LTD. ORDINARY SHARES, NO PAR VALUE PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • June 14th, 2021 • WalkMe Ltd. • Services-prepackaged software • New York
●] Shares Zeta Global Holdings Corp. Class A Common Stock, Par Value $.001 Per Share Underwriting AgreementUnderwriting Agreement • May 10th, 2021 • Zeta Global Holdings Corp. • Services-prepackaged software • New York
This letter is being delivered to Morgan Stanley & Co. LLC acting as representative (the “Representative”) in connection with the offering by Zeta Global Holdings Corp. (the “Company”) of [●] shares of Class A common stock, $.001 par value (the “Common Stock”), of the Company and the lock-up agreement dated [●], 2021 (the “Lock-up Agreement”), executed by you in connection with such offering, and your request for a [waiver/release] dated [●], 2021, with respect to [●] shares of Common Stock (the “Shares”).
] Shares TScan Therapeutics, Inc. COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • April 30th, 2021 • TScan Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
5,000,000 Shares Rhythm Pharmaceuticals, Inc. Common Stock ($0.001 par value) UNDERWRITING AGREEMENTUnderwriting Agreement • February 5th, 2021 • Rhythm Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Rhythm Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, 5,000,000 shares of its common stock, $0.001 par value per share (the “Firm Shares”). The Company also proposes to issue and sell to the several Underwriters not more than an additional 750,000 shares of its common stock, $0.001 par value per share (the “Additional Shares”), if and to the extent that the Representatives shall have determined to exercise, on behalf of the Underwriters, the right to purchase such shares of common stock granted to the Underwriters in Section 2 hereof. The Firm Shares and the Additional Shares are hereinafter collectively referred to as the “Shares.” The shares of common stock, $0.001 par value per share, of the Company to be outstanding after giving effect to the sales contemplated hereby are hereinafter referred to a
] Shares Sigilon Therapeutics, Inc. Common Stock, par value $0.001 UNDERWRITING AGREEMENTUnderwriting Agreement • November 30th, 2020 • Sigilon Therapeutics, Inc. • Pharmaceutical preparations • New York
The undersigned understands that Morgan Stanley & Co. LLC (“Morgan Stanley”) and Jefferies LLC (together with Morgan Stanley, the “Representatives”) propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Sigilon Therapeutics, Inc., a Delaware corporation (the “Company”), providing for the public offering (the “Public Offering”) by the several Underwriters, including the Representatives (the “Underwriters”), of shares (the “Shares”) of the common stock, par value $0.001 per share, of the Company (the “Common Stock”).
●] Shares BIGCOMMERCE HOLDINGS, INC. SERIES 1 COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • November 10th, 2020 • BigCommerce Holdings, Inc. • Services-prepackaged software • New York
11,428,570 Shares ALPHATEC HOLDINGS, INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENT October 13, 2020Underwriting Agreement • October 16th, 2020 • Alphatec Holdings, Inc. • Surgical & medical instruments & apparatus • New York
6,578,947 Shares PERSONALIS, INC. COMMON STOCK, $0.0001 PAR VALUE PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • August 12th, 2020 • Personalis, Inc. • Services-medical laboratories • New York
2U, INC. COMMON STOCK (PAR VALUE $0.001 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • August 10th, 2020 • 2U, Inc. • Services-prepackaged software • New York
The undersigned understands that Morgan Stanley & Co. LLC (“Morgan Stanley”) proposes to enter into an Underwriting Agreement (the “Underwriting Agreement”) with 2U, Inc., a Delaware corporation (the “Company”), providing for the public offering (the “Public Offering”) by the several Underwriters named in Schedule II to the Underwriting Agreement (the “Underwriters”), of shares (the “Shares”) of the common stock, $0.001 par value per share, of the Company (the “Common Stock”).
●] Shares BIGCOMMERCE HOLDINGS, INC. SERIES 1 COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • August 3rd, 2020 • BigCommerce Holdings, Inc. • Services-prepackaged software • New York
●] Shares SELECTQUOTE, INC. COMMON STOCK ($0.01 PAR VALUE PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • May 19th, 2020 • SelectQuote, Inc. • Insurance agents, brokers & service • New York
4,300,000 Shares SI‑BONE, INC. COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • January 24th, 2020 • SI-BONE, Inc. • Surgical & medical instruments & apparatus • New York
SI‑BONE, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule II hereto (the “Underwriters”), for which Morgan Stanley & Co. LLC and BofA Securities, Inc. are acting as representatives (the “Representatives” or “you”), and certain shareholders of the Company (the “Selling Shareholders”) named in Schedule I hereto severally propose to sell to the several Underwriters, an aggregate of 4,300,000 shares of its common stock, par value $.0001 per share (the “Firm Shares”), of which 2,490,053 shares are to be issued and sold by the Company and 1,809,947 shares are to be sold by the Selling Shareholders, each Selling Shareholder selling the amount set forth opposite such Selling Shareholder’s name in Schedule I hereto.
●] Shares REVOLVE GROUP, INC. CLASS A COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • May 28th, 2019 • Revolve Group, LLC • Retail-catalog & mail-order houses • New York
c/o Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 c/o Goldman Sachs & Co. LLC 200 West Street New York, New York 10282Underwriting Agreement • April 26th, 2019 • Uber Technologies, Inc • Services-prepackaged software • New York
COMMON STOCK, $0.000005 PAR VALUE PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • April 1st, 2019 • PagerDuty, Inc. • Services-prepackaged software • New York
●] Shares REVOLVE GROUP, INC. CLASS A COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • October 9th, 2018 • Advance Holdings, LLC • Retail-catalog & mail-order houses • New York
7,352,941 Shares CHARAH SOLUTIONS, INC. COMMON STOCK, PAR VALUE $0.01 PER SHARE UNDERWRITING AGREEMENT June 13, 2018Underwriting Agreement • June 19th, 2018 • Charah Solutions, Inc. • Hazardous waste management • New York
Shares DESPEGAR.COM, CORP. ORDINARY SHARES NO PAR VALUE PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • September 7th, 2017 • Despegar.com, Corp. • Transportation services • New York
Despegar.com, Corp., a company incorporated and existing under the laws of the British Virgin Islands (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule II hereto (the “Underwriters”), for whom Morgan Stanley & Co. LLC, Citigroup Global Markets Inc., Itau BBA USA Securities, Inc. and UBS Securities LLC are acting as representatives (the “Representatives”), and certain shareholders of the Company (the “Selling Shareholders”) named in Schedule I hereto severally propose to sell to the several Underwriters, an aggregate of [ ] ordinary shares, no par value, of the Company (the “Firm Shares”), of which [ ] shares are to be issued and sold by the Company and [ ] shares are to be sold by the Selling Shareholders, each Selling Shareholder selling the amount set forth opposite such Selling Shareholder’s name in Schedule I hereto.
